Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ)

CNY 24.81

(0.36%)

Market Cap (In CNY)

25.21 Billion

Revenue (In CNY)

4.97 Billion

Net Income (In CNY)

1.03 Billion

Avg. Volume

5.9 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
20.64-29.98
PE
-
EPS
-
Beta Value
0.044
ISIN
CNE100000CG8
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Jiaquan Sun
Employee Count
-
Website
https://www.nhwa-group.com
Ipo Date
2008-07-15
Details
Jiangsu Nhwa Pharmaceutical Co., LTD produces and sells central nervous system drugs, and cardiovascular and cerebrovascular drugs in China and internationally. The company offers drugs in the anesthesia, psychiatry, and neurological categories. It also provides APIs in the areas of central nervous system, anesthetic and sedative, and others. The company was founded in 1978 and is headquartered in Xuzhou, China.